Iatrogenic carcinogenesis
Author(s)
Bibliographic Information
Iatrogenic carcinogenesis
Springer-Verlag, 1977
- : us
- : gw
Available at 4 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Includes bibliographies and index
Description and Table of Contents
Description
The purpose of this book, which is written mainly for pharmacothera pists, is to draw the physician's attentions, through specific examples, to iatrogenic (i.e., diagnostically or therapeutically induced) carcino genesis. The book is not intended, however, to arouse public concern. It has been known for some time that each therapeutic measure has a risk-benefit ratio, the estimation of which requires an understanding of carcinogenic side-effects. The number of iatrogenic tumors published so far is not large; however, we assume that there are a number of cases that have not been registered. In the past it was not generally recognized that medical treatment might involve carcinogenic risks; moreover, various therapeutic measures are often used simultaneously so that it may be difficult to trace the cause of tumor formation to a specific agent. Animal experiments and clinical observations during the past few years have contributed to our knowledge of the possible hazards of drugs. We have compiled the most important literature on the subject without, however, attempting completion. The present book may help the pharmacotherapist balance the benefit of a drug against its potential risk, and is thus consistent with the medical principle of nil nocere. We thank Mrs. M. Gomille (Institut fur Toxikologie und Chemothera pie, Deutsches Krebsforschungszentrum, Heidelberg) for her help in the preparation of the manuscript.
Table of Contents
Examples of Iatrogenic Carcinogenesis in the Field of Internal Medicine and its Marginal Areas.- Arsenic.- Chloramphenicol.- Cytostatics.- Organ Transplantation.- Iron-Dextran Complex.- Hydantoin Derivatives.- Phenacetin.- Phenylbutazone.- Diethylstilbestrol.- Tar-Containing Ointmens.- Examples of Iatrogenic Carcinogenesis in the Field of Surgery and its Marginal Areas.- Foreign-Body and Scar Sarcomas.- Skin Tumors at the Site of Smallpox Vaccination Scars.- Primary Carcinoma of the Operated Stomach.- The Stewart-Treves Syndrome.- Tumors of the Colon Following Ureterosigmoidostomy.- Isonicotinic Acid Hydrazide (INH).- Griseofulvin.- Tannin.- Thiouracil.- Glucocorticoids.- Poliomyelitis Vaccine.- Cyclamate.- Ovulation Inhibitors.- Androgenic and Anabolic Steroids.- Rauwolfia Derivatives.- Spironolactones.- Triazene Derivatives and Nitrosoureas.- Streptozotocin.- Hexamethylenetetramine.- Herbae artemesiae absinthii.- Pronethalol, Metronidazole, Niridazole.- Nitrofurane Derivatives.- Cantharidin and Asiaticosides.- Lysergide.- Drugs as Precursors of Nitrosamines.- Inhalation anesthetics.- Discussion.
by "Nielsen BookData"